Description
CETZUP-A — Cetirizine and Ambroxol Together for Advanced Respiratory Relief in Children
CETZUP-A combines Cetirizine HCl 5 mg with Ambroxol 30 mg in a syrup formulation that addresses both allergy symptoms and chest congestion in a single dose. Cetirizine works as an antihistamine that controls sneezing, runny nose and itching associated with allergic conditions, while Ambroxol acts as a mucolytic that thins and loosens mucus, making it easier for children to clear their airways. This combination is particularly useful when allergic symptoms and productive cough occur together, which is common in paediatric respiratory conditions, giving physicians a single-syrup solution instead of prescribing two separate medications. For franchise partners, this practical dual-action logic makes CETZUP-A a genuinely useful addition to their paediatric respiratory range.
Combination Reliability Backed by Certified Manufacturing
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Combining an antihistamine with a mucolytic in a paediatric syrup requires precise formulation to maintain taste, stability and accurate dosing across every batch and CETZUP-A is manufactured under strict quality control to ensure this reliability. For a PCD pharma franchise company in India, offering a dependable allergy-and-mucus combination gives field partners a strong seasonal product to introduce to pediatricians and general physicians.
Product Highlights for Franchise Partners
- Composition: Cetirizine HCl 5 mg + Ambroxol 30 mg
- Dosage Form: Syrup
- Pack Size: 60 ML
- Pack Type: Plastic Bottle for easy dosing and storage
- Key Benefit: Advanced respiratory relief for allergy control, mucus clearance and easier breathing
- Suited For: Distributors and medical representatives expanding their paediatric respiratory range
Franchise partners looking to add a dual-action allergy and mucolytic syrup to their paediatric portfolio can explore this and other formulations through our PCD pharma franchise division, with complete promotional support.
Disclaimer: This is a paediatric product and should be used strictly as advised by a registered medical practitioner.
